Continuous Tremor Assessment During Daily Activities
ETSense: Adaptive Portable Essential Tremor Monitor - Symptomatic Impact Study
2 other identifiers
interventional
39
1 country
2
Brief Summary
The specific aim of this study is to evaluate if tremor severity and quality of life can be improved more using continuous home monitoring along with traditional assessments versus traditional assessments alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 31, 2013
CompletedFirst Posted
Study publicly available on registry
November 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedDecember 10, 2014
December 1, 2014
1.2 years
October 31, 2013
December 9, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Global Impression-Change Scale score
Utilized to measure any improvement or worsening of symptoms relative to a baseline state at enrollment
End of Month 1, End of Month 2, End of Month 3
Secondary Outcomes (3)
Clinical Global Impression-Severity Scale Score
Enrollment, End of Month 1, End of Month 2, End of Month 3
Washington Heights Inwood Genetic Study of Essential Tremor (WHIGET) Tremor Rating Scale
Enrollment, End of Month 1, End of Month 2, End of Month 3
Quality of Life in Essential Tremor Questionnaire
Enrollment, End of Month 1, End of Month 2, End of Month 3
Study Arms (2)
Tremor reports provided
EXPERIMENTALKinesia HomeView utilized to monitor tremor at home and reports provided to treating clinician
Tremor reports not provided
ACTIVE COMPARATORKinesia HomeView utilized to monitor tremor at home and reports not provided to treating clinician
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosed with essential tremor
- Currently taking medication to control tremor
You may not qualify if:
- Cognitive limitations that prevent comprehension or execution of study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Great Lakes NeuroTechnologies Inc.lead
- Rush University Medical Centercollaborator
- Baylor College of Medicinecollaborator
- National Institute on Aging (NIA)collaborator
Study Sites (2)
Rush University Medical Center
Chicago, Illinois, 60612, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dustin Heldman, PhD
Great Lakes NeuroTechnologies
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2013
First Posted
November 7, 2013
Study Start
October 1, 2013
Primary Completion
December 1, 2014
Last Updated
December 10, 2014
Record last verified: 2014-12